Wyss, DFCI, MGH logosHSE, HSCI logos
Harvard i3 Center: Biomaterials to Create T Cell Immunity
Wyss Institute at Harvard University

News

“Immuno-engineering to Improve Immunotherapy” (i3) Center at Harvard University selects Dana-Farber cancer-immunologist Rizwan Romee as its 2021 grant recipient

Romee will advance therapies using natural killer (NK) cells as living drugs by taking biomaterials-based approaches in collaboration with David Mooney’s group at the Wyss Institute and Harvard SEAS ...read more

Harvard “Immuno-engineering to Improve Immunotherapy” (i3) Center at the Wyss Institute awards first grant to Dana-Farber cancer immunologist Eric Smith

...read more

Harvard’s Wyss Institute announces cross-institutional “Immuno-engineering to Improve Immunotherapy (i3)” Center to advance cancer therapy

Harvard University’s Wyss Institute of Biologically Inspired Engineering and its collaborating institutions, the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS), Dana-Farber Cancer Institute (Dana-Farber), and Harvard’s ...read more
The i3 Center is supported by the National Cancer Institute(NCI) and the National Institute On Aging (NIA) of the National Institutes of Health under Award Number U54CA244726. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Copyright © The President and Fellows of Harvard College